This systematic review underscores the evolving landscape of DKA and hypoglycemia management, with evidence supporting the use of subcutaneous insulin, low-dose insulin infusions, and balanced crystalloids to improve outcomes and reduce complications. Here, INS is linked to Hypoglycemia.